1. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis
   Williams Walana et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Imaging of reactive oxygen species using [3H]hydromethidine in mice with cisplatin-induced nephrotoxicity
   Nozomi Takai et al, 2015, EJNMMI Research CrossRef
3. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes
   Williams Walana et al, 2018, Human Immunology CrossRef
4. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
   Mudassier Ahmad et al, 2022, Seminars in Cancer Biology CrossRef
5. ELR-CXC chemokine antagonism is neuroprotective in a rat model of ischemic stroke
   Barry J. Connell et al, 2015, Neuroscience Letters CrossRef
6. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma
   Chun-Min Liang, 2015, World Journal of Hepatology CrossRef
7. Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity
   Ivan K. Domingo et al, 2022, International Journal of Molecular Sciences CrossRef
8. GDC-0941 and CXCL8 (3-72) K11R/G31P combination therapy confers enhanced efficacy against breast cancer
   Xiaodong Li et al, 2020, Future Oncology CrossRef
9. Renoprotective effect of the isoflavonoid biochanin A against cisplatin induced acute kidney injury in mice: Effect on inflammatory burden and p53 apoptosis
   Faiha A. Suliman et al, 2018, International Immunopharmacology CrossRef